Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether a larger dosage of estrogen than the one used
today will secure the development of a normal sized uterus and increase the strength of the
bones in girls and young women with Turner syndrome.
The purpose is also to evaluate whether aortic dilatation is present in this group of
patients, and if the estrogen dosage will influence the emotional well-being and self-esteem
of the patients.
Phase:
Phase 4
Details
Lead Sponsor:
Line Cleemann
Collaborators:
Novo Nordisk A/S The County of Frederiksborg The foundation of Kaptajnløjtnant Harald Jensen and Wife The foundation of Mr. Ivan Nielsen The foundation of Mrs. Olga Bryde